Department of Medicine 2009 Annual Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Rhodes Scholar Magazine? SCHOLAR Please Get in Contact with the 21St Century Leadership Editor; She Will Be Delighted to Hear from You
Ode to the fallen Rhodes Scholars in the First World War Me to We Two Scholars on the scope of social enterprises Olympic participation 21st century leadership The highs and lows 4 Rhodes News 6 Then and Now First year experiences from 1964 and today 8 Rhodes Scholars in research Dr Pardis Sabeti on computational genetics and rock music 10 A year ago in England, ere the storm Marking the centenary of the start of the First World War, we remember the Rhodes Scholars who were lost 6 12 The Oxford Fairy Tale 1964 versus 2014 A current Scholar looks at the magic which underpins the city The difference fifty years makes 14 Oxford News 16 Me to We Two Rhodes Scholars on innovation within social enterprises 18 Life at the Olympics What is it really like to ski at the Olympics? 20 Where are they now? A map illustrating where Rhodes Scholars now live across the globe 16 22 Second Century Campaign innovative social enterprise Fundraising progress and a look at the new Rhodes Scholar Network How to provide people with better choices 24 Oxford through the lens Images from Soufia Siddiqi, winner of Oxford’s graduate photographic competition 26 Rhodes Alumni Bulletin 34 Class Notes 46 An hour with... Lady Williams Rhodes House reminiscences 12 47 Upcoming Rhodes events magical Oxford A unique city, full of the unexpected Contents 2 Editorial information The Rhodes Magazine is published annually in print format by the Rhodes Trust in Oxford and supplemented each year by two electronic updates. Editor: Babette Tegldal, Communications Manager Tel: +44 (0)1865 274787 Email: [email protected] Design: Jamjar Creative Cover illustration: Andrew Smith Back cover: Rhodes Alumni events around the world Photo credits: Lee Atherton for Rhodes House photos, others supplied by Scholars or with credits as specified with images. -
Investment in Early Translational Cancer Research in Canada, 2005–2007
Investment in early Translational Cancer research, 2005–2007 a SPeCIaL rePOrT FrOM THe CaNaDIaN CaNCer reSearCH aLLIaNCe’S SurVey OF GOVerNMeNT aND VOLuNTary SeCTOr INVeSTMeNT IN CaNCer reSearCH February 2011 For additional copies of this publication, please contact: Canadian Cancer Research Alliance (CCRA) 1 University Avenue, Suite 300 Toronto, Ontario M5J 2P1 CANADA Tel.: (416) 915-9222, ext. 5739 Fax: (416) 915-9224 Email: [email protected] This publication is also available at the following address http://www.ccra-acrc.ca. It is formatted for two-sided printing. Permission To Reproduce Except as otherwise specifcally noted, the information in this publication may be reproduced, in part or in whole and by any means, without charge or further permission from the Canadian Cancer Research Alliance (CCRA), provided that due diligence is exercised in ensuring the accuracy of the information reproduced, CCRA is identifed as the source institution, and the reproduction is not represented as being an offcial version of the information, or as having been made in affliation with, or with the endorsement of, CCRA. Suggested Citation: Canadian Cancer Research Alliance (2010). Investment in Early Translational Cancer Research, 2005–2007: A Special Report from the Canadian Cancer Research Alliance’s Survey of Government and Voluntary Sector Investment in Cancer Research. Toronto: CCRA. © Canadian Cancer Research Alliance, 2011 ISBN 978-0-9866841-1-1 (print) / ISBN 978-0-9866841-0-4 (PDF) Aussi offert en français sous le titre : Investissements dans les étapes initiales de la recherche translationnelle sur le cancer, de 2005 à 2007 : un rapport spécial sur l’enquête de l’Alliance canadienne pour la recherche sur le cancer sur les investissements effectués dans la recherche sur le cancer par les organismes gouvernementaux et non gouvernementaux. -
CURRICULUM VITAE Robert C. Welsh, MD, FRCPC, FACC, FAHA, FESC
Welsh, R.C. Page 1 of 66 CURRICULUM VITAE Robert C. Welsh, MD, FRCPC, FACC, FAHA, FESC Current Appointment Professor of Medicine University of Alberta, Faculty of Medicine and Dentistry Business Address 2C2 Walter C Mackenzie Health Science Centre 8440 – 112 Street NW Edmonton, AB T6G 2B7 Canada Office Phone 780 407 3613 Office Fax 780 407 6452 Citizenship Canadian Licensure 011767 College of Physicians and Surgeons of Alberta 499903 Royal College of Physicians and Surgeons of Canada Education and Training 1985 – 1989 Bachelor of Arts (Psychology) University of Saskatchewan Saskatoon, Saskatchewan, Canada 1989 – 1993 Doctor of Medicine (Distinction) University of Saskatchewan Saskatoon, Saskatchewan, Canada 1993 – 1996 Resident, Internal Medicine University of Saskatchewan, Royal University Hospital Saskatoon, Saskatchewan, Canada 1995 – 1996 Chief Resident, Internal Medicine University of Saskatchewan, Royal University Hospital Saskatoon, Saskatchewan, Canada 1996 – 1999 Senior Cardiology Resident University of Alberta, University of Alberta Hospital Edmonton, Alberta, Canada 1997 – 1998 Chief Resident, Cardiology University of Alberta, University of Alberta Hospital Edmonton, Alberta, Canada 1999 – 2000 Fellowship, Interventional Cardiology University of Alberta, University of Alberta Hospital Edmonton, Alberta, Canada Leadership Education and Training 2007 Supervisory Development Program Welsh, R.C. Page 2 of 66 University of Alberta 2014 Canadian Medical Association, Leadership Begins with Self Awareness 2016-2017 Gold College, University -
2015 Annual Report
1 TABLE OF CONTENTS TABLE OF CONTENTS ............................................................................................................................. 2 HISTORY OF THE GAIRDNER FOUNDATION .................................................................................... 3 MISSION ...................................................................................................................................................... 3 NATIONAL AND STUDENT OUTREACH PROGRAMS ....................................................................... 4 MESSAGE FROM THE CHAIR ............................................................................................................... 5 MESSAGE FROM THE PRESIDENT/SCIENTIFIC DIRECTOR ......................................................... 6 2015 YEAR IN REVIEW ............................................................................................................................. 7 REPORT ON 2015 OBJECTIVES ............................................................................................................ 14 THE YEAR AHEAD: OBJECTIVES FOR 2016 ..................................................................................... 16 THE GAIRDNER FOUNDATION VALUES OUR 2015 SPONSORS ................................................... 18 GOVERNANCE ......................................................................................................................................... 20 MEDICAL REVIEW PANEL 2015 ......................................................................................................... -
University of British Columbia Campus Map
THEUNIVERSITYOFBRITISHCOLUMBIA CAMPUSMAP L VisitorParking: 7 e P Parkades g e P TicketDispenserorMeterParkingLots n GREEN Pedestrianzone A COLLEGE d MUSEUMOF ANTHROPOLOGY 1.AquaticCentre 25 2.Angus(Henry)Building(Commerce) 3.AsianCentre P GATE Duke 3 Hall 4.Bookstore Norman 28 ROSE P GARDEN 5.BrockHall(StudentServices) Mackenzie GATE PARKADE Carr 6.BuchananBuilding(Arts) Hall House 4 8 7.CecilGreenParkHouse 36 ROSE GARDEN Carey 8.ChanCentreforthePerformingArts 17 Hall 34 9.ChoiBldg(Inst.ofAsianResearch) 20 22 10.CICSR/ComputerScience D B Belkin WALTERGAGERESIDENCE 11.ComputerScienceBuilding 15 Art P St.Andrews &CONFERENCECENTRE 12 .ContinuingStudies Gallery C E Housing 9 5959StudentUnionBlvd. 13.FirstNationsLonghouse A 14 .ForestryBuilding Nitobe 6 3 Buchanan 15 .FredericWoodTheatre P 26 21 B Memorial Tower 16.GeographyBuilding Garden NORTH P 5 PARKADE 17.GraduateStudentCentre FRASER P 18.HebbTheatre RIVER 19.HenningsBuilding PARKADE 20 .InternationalHouse KOERNER MAIN 21 .LasserreBuilding C 24 LIBRARY LIBRARY GATE 22.Law(Curtis)Building 13 16 2 PLACEVANIER 32 23.MacMillanBuilding RESDENCE 24.MathematicsBuilding 1935LowerMall 33 25.MuseumofAuthropology STUDENT 26.MusicBui lding 11 UNION MacInnes 27.OsborneCentre(Gymnasium) 19 BUILDING Field P TREKKERS 28.Parking&CampusSecurityOffices RESTAURANT 29.PonderosaBuilding 18 Chemistry 30.ScarfeBuilding(Education) 29 2 1 31.SocialWork,Schoolof(JackBellBldg) 31 32.StudentRecreationCentre(SRC) GATE BUS LOOP 33.StudentUnionBuilding(SUB) D 6 P 39 34.Theology,VancouverSchoolof 35.ThunderbirdWinterSportsCentre St.John’s 4 College 36. UniversityCentre 12 30 40 37.UniversityVillage GATE 38.VancouverHospital(UBCSite) P 1 39.WarMemorialGymnasium WEST 40.WesbrookBuilding PARKADE 41.Woodward/IRC 41 E REGENT COLLEGE University 37 Village CEMELabs P P HEALTH Barn SCIENCES 38 Coffee PARKADE Shop GATE 7 RITSUMEIKAN- 23 F UBCHOUSE 6450AgronomyRd. -
Journal of Family Practice Oncology
Journal of Family Practice Oncology Issue Number 22, Spring 2014 | www.fpon.ca Insight into BC’s Colon Screening Program By Dr. Jennifer Telford, Medical Director, Registering eligible patients into the program Provincial Colon Screening Program ensures that the BC Cancer Agency receives FIT results and can refer patients with an Since November 15, 2013 the Colon abnormal FIT or those that are higher than Screening Program has been available average risk to one of 20 health authority across the province. Physicians can register patient coordinators for pre-colonoscopy asymptomatic patients ages 50 to 74 in the assessments. Colon Screening Program as follows: Abnormal FIT Results Colon Screening Program For average risk patients: Jennifer Telford MD MPH FRCPC February 20, 2014 FECAL IMMUNOCHEMICAL TEST (FIT) An abnormal FIT indicates that there www.screeningbc.ca/colon may be bleeding from somewhere in the • Select the ‘Fecal Occult Blood, age 50- colon or rectum. Blood can be present 74, asymptomatic q2y (copy to Colon in the stool for many different reasons, Watch Dr. Jennifer Telford’s hour long Screening Program)’ option on the including hemorrhoids, ulcers, anal fissures, Webcast on the BC’s new Provincial updated Standard Outpatient Laboratory diverticular disease, or inflammation. Colon Screening Program at www.fpon.ca Requisition. – CME Initiatives. • A copy of the FIT report will be sent to the Approximately 15% of individuals screened with Colon Screening Program at the BC Cancer FIT will have an abnormal FIT result and will Agency. require colonoscopy. Of those with an abnormal • For colorectal cancer screening in FIT, 4% will have cancer and approximately 60% individuals less than 50 years of age. -
Department of Medicine Annual Report 2018-2020 Cover: Dr
Department of Medicine Annual Report 2018-2020 Cover: Dr. Verdu and her Research Team Top row: Dr. Heather Galipeau, Dr. Elena Verdu Middle row: Dr. Xuanyu Wang, Dr. Alba Santiago Bottom row: Dr. Marco Constante, Dr. Josie Libertucci A United Team with a common purpose: Dr. Verdu’s Research Team investigates diet-microbiota In addition to being committed to research excellence, this team interactions in chronic intestinal disorders. The team’s line of is committed to each other and to the wellbeing of others. The research includes: the metabolic activity of gut bacteria on the members of this high performing team have been consistent digestion of the dietary protein and gluten, the role of proteolytic supporters of charity events to raise awareness and funds for imbalance in ulcerative colitis, and the contribution of proteolytic the “Canadian Digestive Health Foundation” and “Crohn’s and bacteria to colonic inflammation. The team also explores Colitis of Canada” research, recently surpassing their target mechanisms through which microbes can modulate intestinal fundraising goal at the last virtual GUTSY Walk 2021event. As a inflammation and mechanisms that could help develop therapies to collective team, they have weathered the COVID-19 pandemic and treat celiac disease, and ulcerative colitis. have come together on this cover to illustrate that their common purpose and “united team” approach has not wavered even in this virtually connected world. Our Goals To facilitate the provision of the highest possible quality of care of the medical diseases of adults, giving appropriate consideration to costs and utilities. To take responsibility for the quality of the education programs offered by McMaster University for physicians in training and practice in the disciplines of general internal medicine and the medical subspecialities and to provide many of the planners and teachers for this broad undertaking. -
TRIUMF Team Welcomes Isotope Investment
Canada’s national laboratory for particle and nuclear physics Laboratoire national canadien pour la recherche en physique nucléaire et en physique des particules News Release | For Immediate Release | February 28, 2013, 9:00 a.m. PST TRIUMF Team Welcomes Isotope Investment (Vancouver, BC) --- The CycloTech99 consortium welcomes the investment by Natural Resources Canada (NRCan) through the Isotope Technology Acceleration Program (ITAP) and our partners in provinces, universities, and industry. These funds represent a continued investment from NRCan resulting from our earlier efforts during the Non-reactor-based Isotope Supply Contribution Program (NISP). As announced in February 2012, CycloTech99 has demonstrated the capability to produce the world’s most popular medical isotope, technetium-99m, on medical cyclotrons already installed in Ontario and British Columbia. Our solution in ITAP includes regulatory approval and commercial roll out for a truly national technetium production solution for the benefit of all Canadians, by securing medical isotopes for our patients when the NRU reactor in Chalk River ceases production in 2016. We have a clear pathway to address and stabilize this gap. Principal investigator Paul Schaffer leads the team and is head of TRIUMF’s Nuclear Medicine Division. He said, “The federal government has invested in our team to deliver an innovation for the benefit of all Canadians. We look forward to delivering a domestic solution to the medical isotope crisis in the near future.” “The Harper Government is working to find new ways of producing medical isotopes for the diagnosis of heart disease and cancer in Canadians,” said the Honourable Joe Oliver, Canada’s Minister of Natural Resources. -
Taking It Step by Step: a Guide for Women Diagnosed with Gynecological Cancer
Taking it Step by Step A GUIDE FOR WOMEN DIAGNOSED WITH GYNECOLOGICAL CANCER With great thanks In This Guide Taking it Step by Step: A guide for women 1 Understanding Your Diagnosis _________ 3 diagnosed with gynecological cancer was envisioned and created by the BC/Yukon 2 Treatment Pathway & Timelines _______ 5 Women’s Cancer Information & Support Alliance. This group’s collaborative effort 3 Your Cancer Type _______________________6 includes: women with gynecological cancers; Uterine Cancer __________________________________6 the Canadian Cancer Society BC & Yukon; the Ovarian/Fallopian Tube Cancer ________________9 Gynecologic Tumour Group and Supportive Care Cervical Cancer ________________________________12 Professionals, BC Cancer Agency; Ovarian Cancer Vulvar Cancer __________________________________15 Canada Pacific Yukon Region and UBC School of Vaginal Cancer _________________________________17 Physical Therapy. The production and design for Taking it Step 4 Understanding Your Pathology Report _19 by Step was generously funded by the Cancer Program, Public Health Agency of Canada. The 5 Getting Ready _________________________20 views expressed herein do not represent the views of the Public Health Agency of Canada 6 Questions For Your Medical Team _____21 The printing and ongoing evaluation of Taking 7 Other Common Questions ____________22 it Step by Step is generously funded by the BC Cancer Foundation. The BC Cancer Foundation 8 Your Emotions __________________________23 is an independent charitable organization that raises -
Curriculum Vitae Derryck H Smith, M.D
Curriculum Vitae Derryck H Smith, M.D. F.R.C.P. (C) EDUCATION 1. University of Waterloo, Waterloo, Ontario B.Sc. Chemistry 1970 2. University of Western Ontario, London, Ontario Medical Doctor 1974 3. Internship: Ottawa General Hospital 1974 – 1975 4. Psychiatry Residency: University of British Columbia Completed 1984 5. Fellow of the Royal College of Physicians & Surgeons of Canada Psychiatry 1985 ACADEMIC APPOINTMENT Clinical Professor Emeritus, Department of Psychiatry, University of British Columbia CURRENT POSITIONS 1. Private Practice 2. Member, Division of Child and Adolescent and Forensic Psychiatry, UBC 3. Honorary Staff, BC Children’s Hospital 4. Consultant to Oak Group, Boston, Massachusetts USA AREAS OF PRACTICE AND EXPERTISE 1. Civil litigation, personal injury claims 2. Traumatic Brain Injury - children, teens & adults 3. Attention-Deficit Hyperactivity Disorder – children, teens & adults 4. Disability assessments - including adjudication of disputed claims PEER REVIEW FOR ACADEMIC JOURNALS 1. Canadian Journal of Psychiatry 2. Brain Injury 3. International Journal of Obesity 4. Journal of Psychosomatic Research 5. Advisory Board, International Brain Research Foundation 6. Journal of Child and Adolescent Psychopharmacology 7. Pharmaceutical Medicine 8. The Journal of Neuropsychiatry and Clinical Neurosciences 9. Journal of the American Medical Association TEACHING & SCHOLARLY PRESENTATIONS Lectures (Abbreviated List since 2000) 1. The Advantages of a Medical Care System with Multiple Sources of Funding. Presented at Eldercollege at Capilano College, April 27th 2000 2. Lecture: Efficient Interventions to Alter Behaviour in Children, 8th Annual Paediatric and Adolescent Refresher for General Practitioners, Sheraton Wall Centre Hotel, Vancouver BC, May 5th 2000 Updated: April 2017 Page 1 of 19 Curriculum Vitae Derryck H. -
Lifesciences 2020 – Innovation in Motion
BIV LIFESCIENCES 2020 OFFICIAL PUBLICATION SPONSOR PUBLISHED BY Get ahead of the pack. Social • Google • Websites • Programmatic Glacier Media Digital experts help businesses succeed online. Contact us for a FREE Digital Audit [email protected] US-CHINA PHASE ONE TRADE DEAL: CHINA’S IP COMMITMENTS TO THE LIFE SCIENCES INDUSTRY Written by Jayde Wood & Jennifer Marles A STRONGER INTELLECTUAL pharmaceutical patent applicants to secure agreements will be to move Canada and PROPERTY REGIME IN THE MAKING patent protection in China. China closer in this area. On 15 January 2020, China and the US China will also be required to establish an OPPORTUNITIES FOR LIFE SCIENCES signed an agreement on a Phase One trade effective mechanism for early resolution of COMPANIES deal, which could significantly improve patent disputes, which includes a system the ability of life sciences companies to provide notice to a patent holder that a China’s IP commitments under this to protect their intellectual property in generic drug company is seeking approval Agreement will likely create new China. The first chapter of the Agreement of a version of its patented drug. Such a opportunities for life sciences companies addresses inadequacies in China’s IP regime would be similar in concept to the wishing to market their innovative products regime. The Agreement states that China Patented Medicines (Notice of Compliance) in China, the world’s second-largest life recognizes the importance of IP protection regime that exists in Canada. sciences market. Companies should closely and believes that enhancing IP protection watch the developments of China’s IP and enforcement will boost innovation, PATENT TERM ADJUSTMENT AND regime so that they can assess the potential grow innovation-driven enterprises, and EXTENSION impact on their business and patenting promote high quality economic growth. -
Breast Cancer Companion Guide
Breast Cancer Companion Guide GENEROUSLY FUNDED BY Information Kit © BC Cancer Agency Revised 2013 1 Start Here Be Proactive What’s included in your Kit: 1 Start Here Being diagnosed with breast cancer can be frightening, confusing and overwhelming. You may have many questions • BREAST CANCER COMPANION GUIDE 2 Test Results & Appointments and concerns. This Breast Cancer Information Kit was created to help you, your family and friends during this difficult time. • INTELLIGENT PATIENT GUIDE TO 3 Coping & Support This Breast Cancer Companion Guide is the place to begin and BREAST CANCER will help you interact with the resources in this kit. Sections provides suggested readings, key questions to ask, and 4 Learn About Your Cancer • EXERCISES AFTER BREAST CANCER: additional resources for each step along the journey. A GUIDE FOR WOMEN Keep in mind, that every person with cancer is unique and your 5 Surgery need for information and support will differ from others. You • A NUTRITION GUIDE FOR WOMEN may not require some of the information included in this Kit, WITH BREAST CANCER 6 Adjuvant Therapies nor will you need to read it all at once. Simply take one step at a time. Ask questions, learn about your options, and trust what • ABREAST & THE REST NEWSLETTER 7 Reconstructive Surgery feels right to you. • AFTER BREAST CANCER TREATMENT: 8 Lifestyle The Breast Cancer Information Kit was developed WHAT NEXT? by persons who have experienced breast cancer and 9 Life After Breast Cancer professionals from the Alliance for Breast Cancer • A PARALLEL JOURNEY: MY PARTNER HAS Information & Support, BC Cancer Agency, Victoria Breast BREAST CANCER - HOW CAN I HELP? 10 BC Cancer Foundation Health Centre and the Canadian Cancer Society.